Genedrive PLC | Mutual Funds
Mutual Funds that own Genedrive PLC
CF Odey Investment Funds - Absolute Return Fund
1,997,254
10.63%
0
0.07%
09/29/2017
Amati VCT 2 Plc
361,762
1.93%
11,175
0.15%
01/31/2018
Unicorn AIM VCT Plc
343,750
1.83%
0
0.05%
08/31/2018
Hargreave Hale AIM VCT 1 Plc
166,668
0.89%
1,962
0.06%
09/30/2017
Octopus AIM VCT 2 Plc
164,707
0.88%
4,784
0.06%
05/31/2017
Hargreave Hale AIM VCT 2 Plc
161,445
0.86%
-2,267
0.09%
02/28/2017
Polar Capital Global Healthcare Growth & Income Trust Plc
138,890
0.74%
-2,287
0.01%
09/30/2017
Generali Ambition
113,355
0.6%
-8,423
0.02%
12/30/2016
Hygea VCT Plc
34,300
0.18%
2,617
0.17%
06/30/2017
GF Europe
23,645
0.13%
-6,493
0.02%
12/30/2016
| Address |
48 Grafton Street
Manchester Greater Manchester M13 9XX
United Kingdom
|
|
Employees
|
- |
| Website |
http://epistem.co.uk |
| Updated |
07/08/2019 |
| Genedrive Plc is a holding company, which engages in the development of drugs and disease diagnostics. It operates through the following segments: Preclinical Research Services, Pharmacogenomics Services, and Diagnostics. The Preclinical Research Services segment provides pre-clinical testing services. |
